Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1
Author:
Publisher
Frontiers Media SA
Subject
Immunology,Immunology and Allergy
Reference80 articles.
1. Opportunistic autoimmune disorders: from immunotherapy to immune dysregulation;Kong;Ann N Y Acad Sci,2010
2. Autoimmunity associated with immunotherapy of cancer;Amos;Blood,2011
3. Thyroid dysfunction from antineoplastic agents;Hamnvik;J Natl Cancer Inst,2011
4. Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma;Wolchok;Ann N Y Acad Sci,2013
5. The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network;Voskens;PLoS One,2013
Cited by 102 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ex vivo and in vivo evidence that cigarette smoke-exposed T regulatory cells impair host immunity against Mycobacterium tuberculosis;Frontiers in Cellular and Infection Microbiology;2023-10-26
2. Effectiveness of tacrolimus in a case of immune checkpoint inhibitor-induced hepatotoxicity that was refractory to steroids and mycophenolate mofetil;Clinical Journal of Gastroenterology;2023-07-22
3. Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity;Cancer Immunology Research;2023-07-05
4. Dendritic Cell-Based Cancer Immunotherapy;Handbook of Cancer and Immunology;2022-12-29
5. Clinical Characteristics of ICI-Related Pancreatitis and Cholangitis Including Radiographic and Endoscopic Findings;Healthcare;2022-04-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3